MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Selective α-synuclein overexpression-induced pathology in noradrenergic neurons: a new mouse model for prodromal Parkinson’s disease?

B. Lee, Y. Chen, G. Ganjam, N. Decher, A. Gundlfinger, W.J Berg, M. Britschgi, O. Oertel (Marburg, Germany)

Meeting: MDS Virtual Congress 2020

Abstract Number: 813

Keywords: Alpha-synuclein

Category: Parkinson's Disease: Pathophysiology

Objective: To investigate the phenotype of noradrenergic (NA) neurons in an animal model with selective overexpression of α-synuclein (αSyn) in the locus coeruleus (LC) with histological, physiological and behavioral methods.

Background: Viral vector-based focal overexpression of αSyn is a versatile method for modeling certain aspects of Parkinson’s disease (PD) such as the development of synucleinopathy and neuronal loss. Here we propose to explore the understudied role of the LC in an unprecedented targeted approach in mice. According to Braak staging of PD, the LC is one of the first brain regions affected by Lewy pathology. Notably, the LC is the main source of NA projections and it has many circuit links that are associated with clinical phenotypes of prodromal stages of PD.

Method: We designed a tyrosine hydroxylase (TH) promoter controlled recombinant adeno-associated virus (AAV) 2/5 vector carrying human-wildtype αSyn. A total of 60 animals underwent stereotactic operation targeting the right LC. Histology and whole-cell patch-clamp recording were performed at 9 weeks of αSyn overexpression followed by ongoing long-term evaluation at 24 weeks. The degree of the αSyn burden in selective regions of interest was quantified at 9 and 24 weeks. Motor and non-motor related behavioral assays were also employed.

Results: We report over 98% of the viral transduction rate specifically in the LC neurons. Mild loss of TH+ neurons in the LC was found and markers of αSyn-aggregation (αSyn phosphorylated at Serine 129 and Ubi1) and of gliosis were observed in the LC at 24 weeks. Interestingly, the αSyn overexpressed LC neurons revealed similar pacemaking activity of frequency and after-hyperpolarization amplitude at 9 weeks compared to the control. The whole-brain analysis showed αSyn propagation to distinctive LC-output regions, including the amygdala and the bed nucleus of the stria terminalis (BNST). In addition, motor test results demonstrated no significant alteration in locomotion and gait behaviors in αSyn groups, whereas the results of the non-motor related tasks (gastrointestinal dysfunction and hyposmia) will next be analyzed.

Conclusion: We will present histological, electrophysiological and behavioral data at 9 and 24 weeks in a new mouse model with selective αSyn overexpression in the LC neurons. We will discuss the advantages and limitations of this model for prodromal PD.

To cite this abstract in AMA style:

B. Lee, Y. Chen, G. Ganjam, N. Decher, A. Gundlfinger, W.J Berg, M. Britschgi, O. Oertel. Selective α-synuclein overexpression-induced pathology in noradrenergic neurons: a new mouse model for prodromal Parkinson’s disease? [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/selective-%ce%b1-synuclein-overexpression-induced-pathology-in-noradrenergic-neurons-a-new-mouse-model-for-prodromal-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/selective-%ce%b1-synuclein-overexpression-induced-pathology-in-noradrenergic-neurons-a-new-mouse-model-for-prodromal-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley